Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy

A retrospective study was performed to assess the outcome of patients with diffuse large B cell lymphoma (DLBCL) who did not achieve complete response or who relapsed before and after the use of rituximab. Clinical features and outcome of 816 (425 M/391 F; median age 63 years) patients diagnosed fro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2015-05, Vol.94 (5), p.803-812
Hauptverfasser:	Rovira, Jordina, Valera, Alexandra, Colomo, Lluis, Setoain, Xavier, Rodríguez, Sonia, Martínez-Trillos, Alejandra, Giné, Eva, Dlouhy, Ivan, Magnano, Laura, Gaya, Anna, Martínez, Daniel, Martínez, Antonio, Campo, Elías, López-Guillermo, Armando
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Agents - therapeutic use Female Hematology Humans Lymphoma, Large B-Cell, Diffuse - drug therapy Male Medicine Medicine & Public Health Middle Aged Neoplasm Recurrence, Local - drug therapy Oncology Original Original Article Prognosis Retrospective Studies Rituximab Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!